ArticleAfrican health sciences2025
The efficacy and safety of transcatheter aortic valve replacement in elderly patients with aortic stenosis.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter aortic valve replacement (TAVR) is a promising treatment for aortic stenosis (AS). However, few clinical studies have concentrated on the application of TAVR in elderly AS patients. This study aimed to explore the efficacy and safety of TAVR in elderly patients with AS. Methods: Clinical and imaging data of 143 AS patients undergoing Transcatheter aortic valve replacement were retrospectively analyzed. These patients were divided into non-elderly group (< 65 years old) and elderly group (≥ 65 years old), and the baseline characteristics and clinical outcomes were compared between the two groups. Results: The baseline characteristics showed no significant difference between the two groups. After surgery, echocardiography revealed that the forward flow velocity of aortic valve was higher in the non-elderly group than that in the elderly group (234.2 ± 49.8 cm/s vs. 209.9 ± 57.7 cm/s, P=0.022), while there was no significant difference in other indicators. The operation time (197.4 ± 63.5 min vs. 194.2± 67.8 min, P=0.811), length of hospital stay (14.0±7.3 days vs.14.2±7.6 days, P=0.874), incidence of perioperative complications (2.2% vs. 4.1%, P=1.000), and mortality rate (0.0% vs. 1.0%, P=1.000) sho wed no significant differences between the two groups. Conclusion: Transcatheter aortic valve replacement is an effective and safe therapeutic approach for elderly patients with aortic stenosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.